key: cord-0999239-02o6ujuq
authors: Baumber, Rachel; Panagoda, Prasan; Cremin, James; Flynn, Paul
title: Risk stratification of individuals undergoing surgery after COVID 19 recovery. Response to Br J Anaesth [update; ref 1]
date: 2021-11-20
journal: Br J Anaesth
DOI: 10.1016/j.bja.2021.11.022
sha: 1ff2af9db093f722456664aa63be46187c5c8826
doc_id: 999239
cord_uid: 02o6ujuq

nan

Editor -We read with interest the correspondence from Sivapulle and colleagues, 1 and we agree with their recommendations for further research into patients who have recovered from COVID-19.

As a centre with one of the few peripheral nerve injury units in the UK, we have seen a number of patients presenting for surgery who have nerve injuries as a result of their intensive care stay from COVID-19 infection. Due to the lack of guidelines, we insisted that all of these patients be reviewed by an anaesthetist preoperatively, with appropriate investigations to look for evidence of ongoing cardiac, respiratory or other organ dysfunction that might complicate their perioperative course. In doing so, we followed the recommendations from the British Thoracic society 2 on respiratory followup and emerging evidence of the potential complications from long COVID. 3 We therefore additionally checked ferritin, NT pro-BNP level, D-dimer and troponins, in addition to ensuring recent chest imaging and spirometry.

Out of the 23 patients with a history of COVID-19 who have so far been referred to our peripheral nerve injury unit, 10 have been listed for surgery and were assessed by an anaesthetist. Of these, 90% were intubated and were proned during their stay in the intensive care unit (ICU) for their initial COVID-19 infection. The average ICU length of stay was 57 days (range 10-90 days), 66% had a tracheostomy, 55% had a thromboembolic complication, 88% required renal replacement therapy, 11% required ECMO, 44% had cardiac complications, and 22% suffered a significant neurological complication during their ICU course. In contrast, on their preoperative assessment before surgery, only 22% had biochemical evidence of ongoing cardiac issues with a raised NT pro-BNP or troponin levels. None of these patients had cardiac complications during their initial ICU stay for COVID-19 and so had not had any cardiac follow-up.

Spirometry revealed a restrictive picture in 44% but only 22% had radiological evidence of significant residual fibrosis on CT chest imaging. The number of patients in our cohort demonstrating a restrictive deficit on spirometry is higher than that quoted in previous studies of respiratory followup after COVID-19. Torres-Castro and colleagues 4 found 15% of patients had a restrictive deficit, but this included any patient with confirmed infection. Luppi and colleagues 5 found that 20% of patients who were intubated for COVID-19 had a restrictive deficit. Our cohort is currently small and also includes patients who underwent prolonged periods of proning in ICU. Therefore, the higher number with restrictive deficit in our cohort may reflect the severity of their initial lung injury combined with improvements in treatment over the course of the pandemic leading to increased survival in those with severe lung injury. We found that 55% of patients remained significantly short of breath on minimal exertion and had very limited functional capacity, the majority of these having no radiological evidence of ongoing fibrosis. In addition, many were still suffering with fatigue (33%) or hallucinations (22%).

It is therefore apparent to us that the functional capacity of individuals who have been admitted to ICU with COVID-19 is not completely reflected in the biochemical markers or examination findings, which would usually reveal the presence of significant cardiorespiratory disease during preoperative assessment. This may be unique to those patients who underwent tracheal intubation and there may be some crossover with critical illness neuropathy that deserves due consideration prior to surgery. We support further investigation into the risk stratification of these individuals who present for surgery and recommend that in the meantime, all patients who have been admitted with significant COVID-19 infection be pre-assessed in a high-risk anaesthetic clinic.

The authors declare no conflicts of interest.

Risk stratification of individuals undergoing surgery after COVID-19 recovery

British Thoracic Society Guidance on Respiratory Follow Up of Patients with a Clinico-Radiological Diagnosis of COVID-19 Pneumonia